Aileen X. Wang

1.1k total citations
17 papers, 380 citations indexed

About

Aileen X. Wang is a scholar working on Infectious Diseases, Molecular Biology and Cell Biology. According to data from OpenAlex, Aileen X. Wang has authored 17 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Aileen X. Wang's work include Caveolin-1 and cellular processes (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Aileen X. Wang is often cited by papers focused on Caveolin-1 and cellular processes (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Aileen X. Wang collaborates with scholars based in United States, Netherlands and Switzerland. Aileen X. Wang's co-authors include Eugene J. Barrett, Hong Wang, Kevin W. Aylor, Zhenqi Liu, Hong Wang, Hong Wang, Weidong Chai, Hong Wang, Stéphan Busque and Dora Y. Ho and has published in prestigious journals such as Diabetes, Diabetologia and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Aileen X. Wang

15 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aileen X. Wang United States 9 162 127 100 82 55 17 380
Andreas James Thestrup Pedersen Denmark 10 256 1.6× 264 2.1× 97 1.0× 38 0.5× 68 1.2× 16 454
Tomohito Izumi Japan 8 106 0.7× 115 0.9× 49 0.5× 38 0.5× 140 2.5× 20 417
Jean-Paul Kovalik United States 6 215 1.3× 277 2.2× 51 0.5× 51 0.6× 96 1.7× 7 499
B.L. Wajchenberg Brazil 7 206 1.3× 144 1.1× 51 0.5× 38 0.5× 104 1.9× 9 491
A. L. Thompson Australia 6 230 1.4× 208 1.6× 82 0.8× 39 0.5× 63 1.1× 6 377
Corinne C. Widmer Switzerland 10 88 0.5× 74 0.6× 24 0.2× 71 0.9× 27 0.5× 24 297
Julia S. Jacobs United States 11 114 0.7× 251 2.0× 40 0.4× 49 0.6× 79 1.4× 15 425
Jihoon Shin Japan 11 104 0.6× 100 0.8× 32 0.3× 26 0.3× 96 1.7× 16 348
Jürgen Weiß Germany 12 130 0.8× 161 1.3× 35 0.3× 74 0.9× 82 1.5× 19 406
Madelyn S. Hanson United States 11 166 1.0× 128 1.0× 33 0.3× 37 0.5× 9 0.2× 16 363

Countries citing papers authored by Aileen X. Wang

Since Specialization
Citations

This map shows the geographic impact of Aileen X. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen X. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen X. Wang more than expected).

Fields of papers citing papers by Aileen X. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen X. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen X. Wang. The network helps show where Aileen X. Wang may publish in the future.

Co-authorship network of co-authors of Aileen X. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Aileen X. Wang. A scholar is included among the top collaborators of Aileen X. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen X. Wang. Aileen X. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Goussous, Naeem, et al.. (2025). Outcomes of Kidney Transplantation From Donors on Renal Replacement Therapy. Transplantation Direct. 11(3). e1771–e1771.
2.
Fine, Jeffrey, Brian Howard, Naeem Goussous, et al.. (2024). Impact of Warm Ischemia Time on Donation After Circulatory Death Kidney Transplant Outcomes. Clinical Transplantation. 38(8). e15436–e15436. 2 indexed citations
3.
Goussous, Naeem, et al.. (2024). Outcomes Using High KDPI Kidneys in Recipients Over 65 y of Age. Transplantation Direct. 10(12). e1738–e1738.
4.
Wang, Aileen X., Sai Liu, Maria E. Montez‐Rath, Glenn M. Chertow, & Colin R. Lenihan. (2022). Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients. American Journal of Kidney Diseases. 81(3). 270–280.e1. 4 indexed citations
5.
Uffing, Audrey, Dennis A. Hesselink, Juliana Mansur, et al.. (2022). Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation. Kidney International Reports. 7(6). 1424–1427. 6 indexed citations
6.
Yang, Lu, Cristina Costales, Muthukumar Ramanathan, et al.. (2022). Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study. Journal of Clinical Virology. 153. 105217–105217. 17 indexed citations
7.
Wang, Aileen X., Stéphan Busque, Upinder Singh, et al.. (2021). SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360. 3(1). 133–143. 1 indexed citations
8.
Wong, Sunnie, et al.. (2020). What solid organ transplant healthcare providers should know about renin‐angiotensin‐aldosterone system inhibitors and COVID‐19. Clinical Transplantation. 34(7). e13991–e13991. 2 indexed citations
9.
Wang, Aileen X., Orlando Quintero, Dora Y. Ho, Stéphan Busque, & Colin R. Lenihan. (2020). Influence of immunosuppression on seroconversion against SARS‐CoV‐2 in two kidney transplant recipients. Transplant Infectious Disease. 23(1). e13423–e13423. 17 indexed citations
10.
Puing, Alfredo, Aileen X. Wang, Corinna C. Zygourakis, et al.. (2020). Simultaneous coccidioidomycosis and phaeohyphomycosis in a kidney transplant recipient: A case report and literature review. Transplant Infectious Disease. 22(6). e13365–e13365. 10 indexed citations
11.
Janosevic, Danielle, Aileen X. Wang, & Jay B. Wish. (2018). Difficult Patient Behavior in Dialysis Facilities. Blood Purification. 47(1-3). 254–258. 4 indexed citations
12.
Wang, Hong, Aileen X. Wang, Kevin W. Aylor, & Eugene J. Barrett. (2015). Caveolin-1 phosphorylation regulates vascular endothelial insulin uptake and is impaired by insulin resistance in rats. Diabetologia. 58(6). 1344–1353. 22 indexed citations
13.
Wang, Hong, Aileen X. Wang, Kevin W. Aylor, & Eugene J. Barrett. (2013). Nitric Oxide Directly Promotes Vascular Endothelial Insulin Transport. Diabetes. 62(12). 4030–4042. 88 indexed citations
14.
Wang, Hong, Aileen X. Wang, & Eugene J. Barrett. (2012). Insulin-Induced Endothelial Cell Cortical Actin Filament Remodeling: A Requirement for Trans-Endothelial Insulin Transport. Molecular Endocrinology. 26(8). 1327–1338. 18 indexed citations
15.
Wang, Hong, Aileen X. Wang, & Eugene J. Barrett. (2010). Caveolin-1 is required for vascular endothelial insulin uptake. American Journal of Physiology-Endocrinology and Metabolism. 300(1). E134–E144. 71 indexed citations
16.
Wang, Hong, Aileen X. Wang, Zhenqi Liu, Weidong Chai, & Eugene J. Barrett. (2009). The Trafficking/Interaction of eNOS and Caveolin-1 Induced by Insulin Modulates Endothelial Nitric Oxide Production. Molecular Endocrinology. 23(10). 1613–1623. 43 indexed citations
17.
Wang, Hong, Aileen X. Wang, Zhenqi Liu, & Eugene J. Barrett. (2007). Insulin Signaling Stimulates Insulin Transport by Bovine Aortic Endothelial Cells. Diabetes. 57(3). 540–547. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026